HPS-017 - Stability of daptomycin in icodextrin-based peritoneal dialysis solution

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-017
• By: SUZUKI, Hiroyuki (Division of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Japan)
• Co-author(s): Dr Hiroyuki Suzuki (Division of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan / Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan)
  Kasumi Kudo (Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan / Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan)
  Dr Takashi Uno (Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan)
  Dr Taisuke Konno (Division of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan / Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan)
  Dr Kouji Okada (Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Miyagi, Japan / Division of Clinical Pharmaceutics and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan)
  Dr Yasuyuki Agatsuma (Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan)
  Dr Hitoshi Nakamura (Division of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan)
  Dr Yuriko Murai (Division of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan / Division of Community Medicine and Pharmacy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan)
  
• Abstract:

  Introduction: Peritonitis is a serious complication in patients undergoing peritoneal dialysis (PD), necessitating proactive prevention and treatment to reduce the associated morbidity and mortality, as emphasized in the 2022 International Society for Peritoneal Dialysis guidelines for the prevention and treatment of peritonitis. Patients with..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login